CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Characterization of the interaction between a novel convulsant agent, norbiphen, and GABA\u3csub\u3eA\u3c/sub\u3e and other ligand-gated ion channels
Authors
A. Demuro
Robert F. Halliwell
+3 more
A. Martinez-Torres
R. Miledi
Jiping Su
Publication date
1 January 2002
Publisher
'Elsevier BV'
Doi
Cite
Abstract
A hybrid molecule composed of the antimicrobial, norfloxacin, linked to the non-steroidal anti-inflammatory drug (NSAID), biphenylacetic acid, which we have termed norbiphen, is a lethal convulsant in vivo and an antagonist of rodent GABA receptors in vitro. In the present study, the selectivity, molecular site(s) and mechanism of action of this novel convulsant were investigated using electrophysiological techniques. Sub-maximal GABA-evoked currents recorded from rodent hippocampal neurons were reversibly inhibited by norbiphen (1 μM) to 5±2% of control whereas glutamate, NMDA and glycine activated responses were little or unaffected. Sub-maximal GABA-evoked currents recorded from oocytes expressing recombinant human α1β2γ2s or α1β2 GABA receptors were also reversibly inhibited by norbiphen (1-1000 nM) with an IC (±s.e.m.) of 5.7±1 and 8.8±1 nM, respectively. Similarly, GABA currents recorded from α1β1γ2s, α1β1 and β2γ2s receptors were inhibited with IC s of 16.1±1, 18.8±1 and 4.2±1 nM, respectively. In contrast, norbiphen (100 nM) had little or no effect at ρ1 GABA homomers. At α1β2γ2s receptors, norbiphen had no affect on the GABA reversal potential, and inhibition was not voltage-dependent, suggesting that this compound does not act at the ion channel. The GABA concentration response curve was shifted in a competitive-like fashion by norbiphen (10-300 nM) and a Schild analysis of these data yielded a slope of 0.94±0.1 and a pA of 7.77. Our data reveal a novel, selective and highly potent antagonist of GABA receptors. Norbiphen should be a valuable agent in future studies of this receptor complex. © 2002 Elsevier Science Ltd. All rights reserved. A A 50 50 C 2
Similar works
Full text
Available Versions
Scholarly Commons
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:scholarlycommons.pacific.e...
Last time updated on 03/06/2021
Pacific McGeorge School of Law
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:scholarlycommons.pacific.e...
Last time updated on 31/08/2021